Skip to main content

Cepheid Licenses Scorpions Technology from DxS

NEW YORK, July 20 (GenomeWeb News) - Cepheid has licensed a probe technology for real-time PCR from DxS, the company said today.

 

Under the agreement, Cepheid may use DxS' Scorpions technology for all markets except clinical diagnostics, wine production, and the detection of chemicals used in agriculture. Scorpions probes contain a PCR primer covalently linked to a fluorescent probe.

 

Cepheid plans to use the technology for food, agriculture, and environmental testing, starting with recreational water testing, combining it with its own SmartCycler and GeneXpert systems.

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.